The Rising Costs of Health Care

A Decade of Health Care Cost Growth: Impact on the American Family

image of stethoscope, dollars, and prescription

How do soaring health care costs affect the finances of the average American family? A new RAND Health study shows that the doubling of health costs between 1999 and 2009 largely wiped out an average family's real income gains. In fact, in 2009 the family had a net gain of only $95 per month. If health care costs had tracked general inflation over the decade, the family would have had nearly $5,400 more in 2009.

Rising Costs of Health Care — May 24, 2011

On May 24, 2011, the RAND Corporation presented “Rising Costs of Health Care” as part of its Issues in Focus public outreach series in Santa Monica, California. The program featured Arthur Kellermann, vice president and director of RAND Health.

Consumers May Have More Control Over Health Care Costs Than Previously Thought

The historic RAND Health Insurance Experiment found that patients had little or no control over their health care spending once they began to receive a physician's care, but this has changed for those enrolled in consumer-directed health plans.

Consolidation of Health Plans May Help Lower Hospital Costs

Increased consolidation among health plans nationally may benefit consumers by lowering hospital prices, at least in those regions where health plans are the most consolidated.

The Health Insurance Experiment

RAND's pioneering Health Insurance Experiment shaped current understanding of how cost sharing affects health care use and health outcomes.

22 RAND Researchers Featured at ASHEcon 2012

RAND researchers will be featured in 40 roles at the Conference of American Society of Health Economists (ASHEcon), as session chairs, presenters, authors or discussants, June 10-13 in Minneapolis. View our guide to RAND research at ASHEcon 2012 via the link below.

How the Affordable Care Act Will Affect Coverage and Costs in Five States

RAND Health, in partnership with The Council of State Governments (CSG), used the RAND COMPARE simulation model to assess the likely effects of the ACA on insurance coverage and state government health-care spending in five states (California, Connecticut, Illinois, Montana, and Texas). The percentage of residents with health care coverage is expected to rise significantly in all five states; health care spending will also increase in four of the five states (all except Connecticut).

Growth of Consumer-Directed Health Plans to One-Half of All Employer-Sponsored Insurance Could Save $57 Billion Annually — 2012

Enrollment is increasing in consumer-directed health insurance plans, which feature high deductibles and a personal health care savings account.

Cost-effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis — 2012

This study assesses, from a Swedish societal perspective, the cost effectiveness of interferon β-1b (IFNB-1b) after an initial clinical event suggestive of multiple sclerosis (MS) (ie, early treatment) compared with treatment after onset of clinically definite MS (CDMS) (ie, delayed treatment).

Survey Results Show That Adults Are Willing to Pay Higher Insurance Premiums for Generous Coverage of Specialty Drugs — 2012

This study estimated how healthy people value insurance coverage of specialty drugs, defined as high-cost drugs that treat cancer and other serious health conditions like multiple sclerosis, by quantifying willingness to pay via a survey.

An Analysis of Whether Higher Health Care Spending in the United States Versus Europe Is 'Worth It' in the Case of Cancer — 2012

The higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States.

Consumers' and Providers' Responses to Public Cost Reports, and How to Raise the Likelihood of Achieving Desired Results — 2012

Public reporting of health care costs is intended to motivate consumers to choose lower cost providers, and motivate providers to lower costs to retain market share. Measures should be chosen based on which pathway policymakers intend to influence.

My RAND ?

Saved Items

Recommended